D.S. Allen

871 total citations
19 papers, 485 citations indexed

About

D.S. Allen is a scholar working on Oncology, Cancer Research and Genetics. According to data from OpenAlex, D.S. Allen has authored 19 papers receiving a total of 485 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Cancer Research and 6 papers in Genetics. Recurrent topics in D.S. Allen's work include Cancer Risks and Factors (10 papers), Estrogen and related hormone effects (6 papers) and Breast Cancer Treatment Studies (5 papers). D.S. Allen is often cited by papers focused on Cancer Risks and Factors (10 papers), Estrogen and related hormone effects (6 papers) and Breast Cancer Treatment Studies (5 papers). D.S. Allen collaborates with scholars based in United Kingdom, Netherlands and South Africa. D.S. Allen's co-authors include Ian S. Fentiman, IS Fentiman, R.D. Bulbrook, Bianca De Stavola, H. Hamed, John W. Moore, D.Y. Wang, H. G. Kwa, J.L. Hayward and I. H. Gravelle and has published in prestigious journals such as American Journal of Epidemiology, Journal of Clinical Epidemiology and British Journal of Cancer.

In The Last Decade

D.S. Allen

19 papers receiving 464 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D.S. Allen United Kingdom 14 225 132 109 102 78 19 485
R K Ross United States 6 210 0.9× 114 0.9× 76 0.7× 104 1.0× 52 0.7× 7 406
W. Braendle Germany 15 160 0.7× 187 1.4× 55 0.5× 142 1.4× 44 0.6× 66 618
HV Thomas United Kingdom 4 240 1.1× 234 1.8× 61 0.6× 79 0.8× 40 0.5× 5 372
Mei-Tzu C. Tang United States 11 392 1.7× 111 0.8× 155 1.4× 44 0.4× 63 0.8× 11 565
J. Papadiamantis Greece 9 281 1.2× 188 1.4× 173 1.6× 59 0.6× 26 0.3× 15 462
Sarah F. Marshall United States 12 225 1.0× 179 1.4× 96 0.9× 68 0.7× 31 0.4× 14 697
George Rennie Australia 9 95 0.4× 129 1.0× 91 0.8× 92 0.9× 98 1.3× 13 487
Elwine Halewijn Netherlands 8 374 1.7× 159 1.2× 109 1.0× 101 1.0× 59 0.8× 16 711
P Stattin Sweden 7 200 0.9× 85 0.6× 70 0.6× 215 2.1× 31 0.4× 7 560
Brian Pruitt United States 10 319 1.4× 73 0.6× 80 0.7× 40 0.4× 32 0.4× 20 481

Countries citing papers authored by D.S. Allen

Since Specialization
Citations

This map shows the geographic impact of D.S. Allen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.S. Allen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.S. Allen more than expected).

Fields of papers citing papers by D.S. Allen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D.S. Allen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.S. Allen. The network helps show where D.S. Allen may publish in the future.

Co-authorship network of co-authors of D.S. Allen

This figure shows the co-authorship network connecting the top 25 collaborators of D.S. Allen. A scholar is included among the top collaborators of D.S. Allen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D.S. Allen. D.S. Allen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Kontos, Michalis, et al.. (2011). Factors influencing loco-regional relapse in older breast cancer patients treated with tumour resection and tamoxifen. European Journal of Surgical Oncology. 37(12). 1051–1058. 9 indexed citations
2.
Fentiman, IS & D.S. Allen. (2010). γ-Glutamyl transferase and breast cancer risk. British Journal of Cancer. 103(1). 90–93. 44 indexed citations
3.
Irvine, Tracey, D.S. Allen, Cheryl Gillett, H. Hamed, & Ian S. Fentiman. (2009). Prognosis of synchronous bilateral breast cancer. British journal of surgery. 96(4). 376–380. 24 indexed citations
4.
Fentiman, Ian S., D.S. Allen, & George T. H. Ellison. (2007). The impact of the Occupation of Guernsey 1940-1945 on breast cancer risk factors and incidence. International Journal of Clinical Practice. 61(6). 937–943. 17 indexed citations
5.
Fentiman, Ian S., A M Hanby, D.S. Allen, T J Key, & Elaine N. Meilahn. (2005). Hormone dependency of breast tumours developing in the Guernsey Cohort Study. Breast Cancer Research and Treatment. 97(2). 205–208. 3 indexed citations
6.
Fentiman, Ian S., D.S. Allen, & H. Hamed. (2005). Smoking and prognosis in women with breast cancer. International Journal of Clinical Practice. 59(9). 1051–1054. 44 indexed citations
7.
Allen, D.S.. (2002). Determinants of the Availability and Accuracy of Self-reported Birth Weight in Middle-aged and Elderly Women. American Journal of Epidemiology. 155(4). 379–384. 39 indexed citations
8.
Bulbrook, R.D., et al.. (2000). True. British Journal of Cancer. 82(9). 1577–1584. 37 indexed citations
9.
DeStavola, Bianca, D.S. Allen, Ian S. Fentiman, et al.. (1997). Breast cancer risk is positively associated with height. Breast Cancer Research and Treatment. 43(2). 123–128. 11 indexed citations
10.
Key, T J, J. B. Brown, C Hermon, et al.. (1996). A prospective study of urinary oestrogen excretion and breast cancer risk. British Journal of Cancer. 73(12). 1615–1619. 47 indexed citations
11.
Stepniewska, Kasia, D.S. Allen, IS Fentiman, et al.. (1995). Serum prolactin levels and their relationship to survival in women with operable breast cancer. Journal of Clinical Epidemiology. 48(7). 959–968. 23 indexed citations
12.
Allen, D.S., et al.. (1994). BONE DENSITY OF NORMAL WOMEN IN RELATION TO ENDOGENOUS AND EXOGENOUS OESTROGENS. Lara D. Veeken. 33(9). 808–815. 19 indexed citations
13.
Overvad, Kim, Dennis Y. Wang, D.S. Allen, et al.. (1993). Copper in Human Mammary Carcinogenesis: A Case-Cohort Study. American Journal of Epidemiology. 137(4). 409–14. 20 indexed citations
14.
Allen, D.S., R.D. Bulbrook, M.A. Chaudary, et al.. (1991). Recurrence and survival rates in British and Japanese women with breast cancer. Breast Cancer Research and Treatment. 18(S1). S131–S134. 18 indexed citations
15.
Key, Timothy J., Malcolm C. Pike, John W. Moore, et al.. (1989). The relationships of SHBG with current and previous use of oral contraceptives and oestrogen replacement therapy. Contraception. 39(2). 179–186. 16 indexed citations
16.
Wang, D.Y., Bianca De Stavola, R.D. Bulbrook, et al.. (1988). The permanent effect of reproductive events on blood prolactin levels and its relation to breast cancer risk: a population study of postmenopausal women. European Journal of Cancer and Clinical Oncology. 24(7). 1225–1231. 63 indexed citations
17.
Moore, John W., T J Key, G.M.G. Clark, et al.. (1988). Concentrations of Sex-Hormone-Binding-Globulin (SHBG) in a population of normal women: Relationship to risk factors for breast cancer. Steroids. 52(4). 391–392. 6 indexed citations
18.
Wang, D.Y., C. Ian Mockridge, Vera Fantl, et al.. (1988). Urinary epidermal growth factor excretion and breast cancer risk. European Journal of Cancer and Clinical Oncology. 24(6). 1049–1053. 2 indexed citations
19.
Wang, D.Y., Bianca De Stavola, R.D. Bulbrook, et al.. (1987). The relationship between blood prolactin levels and risk of breast cancer in premenopausal women. European Journal of Cancer and Clinical Oncology. 23(10). 1541–1548. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026